lamivudine
- Product NDC
- 68999-706
- 11-digit product format
- 689990706
- Labeler code
- 68999
- Product ID
- 68999-706_476c3997-b596-17d2-e063-6394a90a6ca1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamivudine oral
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Chartwell Govermental & Specialty RX, LLC.
- Application
- ANDA203564
- Marketing category
- ANDA
- Marketing start
- 2014-10-31
- Substance
- LAMIVUDINE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- lamivudine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LAMIVUDINE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2T8Q726O95 |
| Rxcui | 199148 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68999-706-24 | lamivudine | 2 in 1 BOX | SOLUTION | 2 | | 2 |
| 68999-706-24 | lamivudine | 10 in 1 TRAY | SOLUTION | 10 | | 2 |
| 68999-706-30 | lamivudine | 30 mL in 1 CUP | SOLUTION | 30 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68999-706-24 | 68999070624 | 2 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30) | 2 tray | 2025-12-24 | No | No | Historical |
| 68999-706-30 | 68999070630 | 30 mL in 1 CUP | 30 ml | | | | Historical |